Alam Kamran Insider Trades

Insider Trading History

Track insider trading activity for Alam Kamran. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $8M 1,442,131 shares
Last Trade
Feb 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.48k 1,655 shares
$4.52
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $8.01M 1,443,786 shares
Last Trade
Jan 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$110k 23,849 shares
$4.61
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $8.15M 1,467,635 shares
Last Trade
Jan 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$375k 78,968 shares
$4.75
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $8.58M 1,546,603 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.87M 590,000 shares
$4.86
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $6.59M 1,187,603 shares
Last Trade
Aug 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$155k 54,491 shares
$2.85
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $6.89M 1,242,094 shares
Last Trade
Mar 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.4k 29,843 shares
$1.69
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $7.06M 1,271,937 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.59M 862,000 shares
$1.85
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $4.67M 840,937 shares
Last Trade
Feb 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.94k 1,288 shares
$1.51
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $4.67M 842,225 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 590,413 shares
$1.71
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.04M 187,582 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 187,582 shares
$1.55
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.43M 258,042 shares
Last Trade
Aug 24, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$76.9k 33,000 shares
$2.33
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.62M 291,042 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.35k 6,230 shares
$0.70
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
CHIEF FINANCIAL OFFICER
Holding Value $69.2k 12,462 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.71k 12,462 shares
$0.70
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.58M 284,812 shares
Last Trade
Feb 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 205,975 shares
$1.07
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.48M 266,121 shares
Last Trade
Aug 23, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.5k 3,325 shares
$3.47
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.5M 269,446 shares
Last Trade
Aug 22, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$34k 9,717 shares
$3.50
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.61M 290,645 shares
Last Trade
Aug 18, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$72k 18,958 shares
$3.80
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $222k 40,000 shares
Last Trade
Apr 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$522k 80,000 shares
$6.52
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $444k 80,000 shares
Last Trade
Feb 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477k 80,000 shares
$5.96
$5.55
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Financial Officer
Holding Value $1.67M 300,215 shares
Last Trade
Aug 20, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$199k 11,840 shares
$16.78
$5.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up